Letrozole, tablets 2.5 mg, 30 pcs.

It is an antitumor agent. It is a non-steroidal inhibitor of aromatase, an enzyme that participates in the synthesis of estrogen in postmenopausal women.

Indications

Active ingredient

Composition

Associates:

Lactose monohydrate – 50 mg,

sodium carboxymethyl starch – 2.5 mg,

silicon dioxide colloid – 0.5 mg,

microcrystalline cellulose – 28 mg,

crospovidone – 4 mg,

corn starch pregelatinized – 11.5 mg,

magnesium stearate – 1 mg.

Composition of the film coating:

Opadray Y 1-7000 (hypromellose, titanium dioxide, macrogol (polyethylene glycol) – 3.73 mg, iron oxide yellow dye – 0.27 mg.

How to take, the dosage

Special Instructions

In patients with a CKG of less than 10 ml/min, the safety of letrozole has not been studied, so the balance between the expected therapeutic effect and the possible risk of treatment should be carefully weighed if it is necessary to use it in these cases.

The effects of letrozole may decrease the ability to concentrate and the speed of psychomotor reactions, therefore it is recommended to avoid driving and other potentially dangerous activities during treatment.

Contraindications

Side effects

Possible: headache, nausea, peripheral edema, general weakness, hot flashes, thinning hair, skin rash, vomiting, dyspepsia, weight gain, muscular-skeletal pain, anorexia, vaginal bleeding, leukorrhea, constipation, dizziness, increased appetite, increased sweating.

Rarely: shortness of breath, thrombophlebitis, bloody discharge from the vagina.

Similarities